Novel derivatives having 2,3-dihydro-1h-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same
US-2026098038-A1 · Apr 9, 2026 · US
Green Cross Corp holds 101 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 101 |
| Recent patents | 22 |
| First publication | Apr 14, 2015 |
| Latest publication | Apr 9, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026098038-A1 · Apr 9, 2026 · US
US-2026092264-A1 · Apr 2, 2026 · US
US-12534518-B2 · Jan 27, 2026 · US
US-12522602-B2 · Jan 13, 2026 · US
US-2025381140-A1 · Dec 18, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026098038-A1 · Apr 9, 2026 · US
US-2026092264-A1 · Apr 2, 2026 · US
US-12534518-B2 · Jan 27, 2026 · US
US-12522602-B2 · Jan 13, 2026 · US
US-2025381140-A1 · Dec 18, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P43/00 | 23 |
| A61P35/00 | 21 |
| A61K2039/505 | 19 |
| A61K9/0019 | 17 |
| C12Y301/06013 | 17 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 99 |
| Human Necessities | 86 |
| Operations & Transport | 11 |
| Physics | 10 |
| Cross-Sectional Technologies | 5 |
Answers are generated from the same data shown on this page.